ID   KPCD_RAT                Reviewed;         673 AA.
AC   P09215; Q6DG48; Q9JK29; Q9JL03;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-OCT-2024, entry version 227.
DE   RecName: Full=Protein kinase C delta type {ECO:0000305};
DE            EC=2.7.11.13 {ECO:0000250|UniProtKB:Q05655};
DE   AltName: Full=nPKC-delta;
DE   Contains:
DE     RecName: Full=Protein kinase C delta type regulatory subunit;
DE   Contains:
DE     RecName: Full=Protein kinase C delta type catalytic subunit;
DE     AltName: Full=Sphingosine-dependent protein kinase-1;
DE              Short=SDK1;
GN   Name=Prkcd {ECO:0000312|RGD:67383}; Synonyms=Pkcd;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=2834397; DOI=10.1016/s0021-9258(18)68732-0;
RA   Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y.;
RT   "The structure, expression, and properties of additional members of the
RT   protein kinase C family.";
RL   J. Biol. Chem. 263:6927-6932(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar Kyoto;
RX   PubMed=10721703; DOI=10.1016/s0378-1119(99)00539-9;
RA   Kurkinen K.M.A., Keinanen R.A., Karhu R., Koistinaho J.;
RT   "Genomic structure and chromosomal localization of the rat PKCdelta-gene.";
RL   Gene 242:115-123(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10708593; DOI=10.1006/bbrc.2000.2331;
RA   Ueyama T., Ren Y., Ohmori S., Sakai K., Tamaki N., Saito N.;
RT   "cDNA cloning of an alternative splicing variant of protein kinase C delta
RT   (PKC deltaIII), a new truncated form of PKCdelta, in rats.";
RL   Biochem. Biophys. Res. Commun. 269:557-563(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 123-286.
RX   PubMed=3691811; DOI=10.1016/0014-5793(87)80564-1;
RA   Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y.;
RT   "Identification of three additional members of rat protein kinase C family:
RT   delta-, epsilon- and zeta-subspecies.";
RL   FEBS Lett. 226:125-128(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 142-153.
RX   PubMed=1915352; DOI=10.1111/j.1432-1033.1991.tb16248.x;
RA   Olivier A.R., Parker P.J.;
RT   "Expression and characterization of protein kinase C-delta.";
RL   Eur. J. Biochem. 200:805-810(1991).
RN   [7]
RP   MUTAGENESIS OF THR-505, AND PHOSPHORYLATION AT THR-505.
RX   PubMed=9677322; DOI=10.1042/bj3330631;
RA   Garcia-Paramio P., Cabrerizo Y., Bornancin F., Parker P.J.;
RT   "The broad specificity of dominant inhibitory protein kinase C mutants
RT   infers a common step in phosphorylation.";
RL   Biochem. J. 333:631-636(1998).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, CLEAVAGE BY CASPASE-3, AND ACTIVITY
RP   REGULATION.
RX   PubMed=12855683; DOI=10.1074/jbc.m305294200;
RA   Hamaguchi A., Suzuki E., Murayama K., Fujimura T., Hikita T., Iwabuchi K.,
RA   Handa K., Withers D.A., Masters S.C., Fu H., Hakomori S.;
RT   "Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified
RT   as the kinase domain of protein kinase C delta.";
RL   J. Biol. Chem. 278:41557-41565(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [10]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-64 AND TYR-155.
RX   PubMed=17562707; DOI=10.1074/jbc.m703661200;
RA   DeVries-Seimon T.A., Ohm A.M., Humphries M.J., Reyland M.E.;
RT   "Induction of apoptosis is driven by nuclear retention of protein kinase C
RT   delta.";
RL   J. Biol. Chem. 282:22307-22314(2007).
RN   [11]
RP   PHOSPHORYLATION AT THR-505.
RX   PubMed=17569658; DOI=10.1074/jbc.m701676200;
RA   Rybin V.O., Guo J., Gertsberg Z., Elouardighi H., Steinberg S.F.;
RT   "Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation
RT   loop phosphorylation in cardiomyocytes.";
RL   J. Biol. Chem. 282:23631-23638(2007).
RN   [12]
RP   PHOSPHORYLATION AT TYR-311; TYR-332 AND THR-505.
RX   PubMed=18550549; DOI=10.1074/jbc.m802396200;
RA   Sumandea M.P., Rybin V.O., Hinken A.C., Wang C., Kobayashi T., Harleton E.,
RA   Sievert G., Balke C.W., Feinmark S.J., Solaro R.J., Steinberg S.F.;
RT   "Tyrosine phosphorylation modifies protein kinase C delta-dependent
RT   phosphorylation of cardiac troponin I.";
RL   J. Biol. Chem. 283:22680-22689(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-311; SER-643 AND SER-662, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-123.
RX   PubMed=9687370; DOI=10.1016/s0969-2126(98)00090-2;
RA   Pappa H., Murray-Rust J., Dekker L.V., Parker P.J., McDonald N.Q.;
RT   "Crystal structure of the C2 domain from protein kinase C-delta.";
RL   Structure 6:885-894(1998).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that plays contrasting roles
CC       in cell death and cell survival by functioning as a pro-apoptotic
CC       protein during DNA damage-induced apoptosis, but acting as an anti-
CC       apoptotic protein during cytokine receptor-initiated cell death, is
CC       involved in tumor suppression, is required for oxygen radical
CC       production by NADPH oxidase and acts as a positive or negative
CC       regulator in platelet functional responses. Upon DNA damage, activates
CC       the promoter of the death-promoting transcription factor BCLAF1/Btf to
CC       trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In
CC       response to oxidative stress, interact with and activate CHUK/IKKA in
CC       the nucleus, causing the phosphorylation of p53/TP53. In the case of ER
CC       stress or DNA damage-induced apoptosis, can form a complex with the
CC       tyrosine-protein kinase ABL1 which trigger apoptosis independently of
CC       p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or
CC       MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor
CC       of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via
CC       the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is
CC       required for the activation of the apoptosis regulators BAX and BAK,
CC       which trigger the mitochondrial cell death pathway. Can phosphorylate
CC       MCL1 and target it for degradation which is sufficient to trigger for
CC       BAX activation and apoptosis. Is required for the control of cell cycle
CC       progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate
CC       13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S
CC       phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the
CC       cyclin CCNA2 promoter activity. In response to UV irradiation can
CC       phosphorylate CDK1, which is important for the G2/M DNA damage
CC       checkpoint activation. Can protect glioma cells from the apoptosis
CC       induced by TNFSF10/TRAIL, probably by inducing increased
CC       phosphorylation and subsequent activation of AKT1. Can also act as
CC       tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-
CC       formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required
CC       for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase
CC       activity, and regulates TNF-elicited superoxide anion production in
CC       neutrophils, by direct phosphorylation and activation of NCF1 or
CC       indirectly through MAPK1/3 (ERK1/2) signaling pathways. Involved in
CC       antifungal immunity by mediating phosphorylation and activation of
CC       CARD9 downstream of C-type lectin receptors activation, promoting
CC       interaction between CARD9 and BCL10, followed by activation of NF-
CC       kappa-B and MAP kinase p38 pathways (By similarity). May also play a
CC       role in the regulation of NADPH oxidase activity in eosinophil after
CC       stimulation with IL5, leukotriene B4 or PMA. In collagen-induced
CC       platelet aggregation, acts a negative regulator of filopodia formation
CC       and actin polymerization by interacting with and negatively regulating
CC       VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors,
CC       regulates differentially platelet dense granule secretion; acts as a
CC       positive regulator in PAR-mediated granule secretion, whereas it
CC       negatively regulates CD36/GP4-mediated granule release. Phosphorylates
CC       MUC1 in the C-terminal and regulates the interaction between MUC1 and
CC       beta-catenin (By similarity). The catalytic subunit phosphorylates 14-
CC       3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent
CC       fashion. Phosphorylates ELAVL1 in response to angiotensin-2 treatment
CC       (By similarity). Phosphorylates mitochondrial phospholipid scramblase 3
CC       (PLSCR3), resulting in increased cardiolipin expression on the
CC       mitochondrial outer membrane which facilitates apoptosis (By
CC       similarity). Phosphorylates SMPD1 which induces SMPD1 secretion (By
CC       similarity). {ECO:0000250|UniProtKB:P28867,
CC       ECO:0000250|UniProtKB:Q05655}.
CC   -!- FUNCTION: Truncated isoform 2 is inactive.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13; Evidence={ECO:0000250|UniProtKB:Q05655};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10027};
CC   -!- ACTIVITY REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-505 (activation loop of
CC       the kinase domain), Ser-643 (turn motif) and Ser-662 (hydrophobic
CC       region), need to be phosphorylated for its full activation. Activated
CC       by caspase-3 (CASP3) cleavage during apoptosis. After cleavage, the
CC       pseudosubstrate motif in the regulatory subunit is released from the
CC       substrate recognition site of the catalytic subunit, which enables
CC       PRKCD to become constitutively activated. The catalytic subunit which
CC       displays properties of a sphingosine-dependent protein kinase is
CC       activated by D-erythro-sphingosine (Sph) or N,N-dimethyl-D-
CC       erythrosphingosine (DMS) or N,N,N-trimethyl-D-erythrosphingosine (TMS),
CC       but not by ceramide or Sph-1-P and is strongly inhibited by
CC       phosphatidylserine. {ECO:0000269|PubMed:12855683}.
CC   -!- SUBUNIT: Interacts with PDPK1 (via N-terminal region). Interacts with
CC       RAD9A (By similarity). Interacts with CDCP1. Interacts with MUC1.
CC       Interacts with VASP. Interacts with CAVIN3. Interacts with PRKD2 (via
CC       N-terminus and zing-finger domain 1 and 2) in response to oxidative
CC       stress; the interaction is independent of PRKD2 tyrosine
CC       phosphorylation (By similarity). Interacts with PLSC3; interaction is
CC       enhanced by UV irradiation (By similarity).
CC       {ECO:0000250|UniProtKB:P28867, ECO:0000250|UniProtKB:Q05655}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17562707}. Nucleus
CC       {ECO:0000269|PubMed:17562707}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:17562707}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q05655}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q05655}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q05655}. Endomembrane system
CC       {ECO:0000250|UniProtKB:Q05655}. Note=Translocates to the mitochondria
CC       upon apoptotic stimulation. Upon activation, translocates to the plasma
CC       membrane followed by partial location to the endolysosomes.
CC       {ECO:0000250|UniProtKB:Q05655}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PKC-delta-I;
CC         IsoId=P09215-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKC-delta-III;
CC         IsoId=P09215-2; Sequence=VSP_004742;
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type region 1
CC       (C1A) and 2 (C1B), is the diacylglycerol sensor.
CC   -!- DOMAIN: The C2 domain is a non-calcium binding domain. It binds
CC       proteins containing phosphotyrosine in a sequence-specific manner (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated and/or phosphorylated at Thr-505, within the
CC       activation loop; phosphorylation at Thr-505 is not a prerequisite for
CC       enzymatic activity (PubMed:17569658, PubMed:9677322).
CC       Autophosphorylated at Ser-299 (By similarity). Upon TNFSF10/TRAIL
CC       treatment, phosphorylated at Tyr-155; phosphorylation is required for
CC       its translocation to the endoplasmic reticulum and cleavage by caspase-
CC       3 (PubMed:17562707). Phosphorylated at Tyr-311, Tyr-332 and Tyr-565;
CC       phosphorylation of Tyr-311 and Tyr-565 following thrombin or zymosan
CC       stimulation potentiates its kinase activity (PubMed:18550549).
CC       Phosphorylated by protein kinase PDPK1; phosphorylation is inhibited by
CC       the apoptotic C-terminal cleavage product of PKN2 (By similarity).
CC       Phosphorylated at Tyr-311 and Tyr-332 by SRC; phosphorylation leads to
CC       enhanced autophosphorylation at Thr-505 (PubMed:18550549).
CC       Phosphorylated at Tyr-311 through a SYK and SRC mechanism downstream of
CC       C-type lectin receptors activation, promoting its activation (By
CC       similarity). {ECO:0000250|UniProtKB:P28867,
CC       ECO:0000250|UniProtKB:Q05655, ECO:0000269|PubMed:17562707,
CC       ECO:0000269|PubMed:17569658, ECO:0000269|PubMed:18550549,
CC       ECO:0000269|PubMed:9677322}.
CC   -!- PTM: Proteolytically cleaved into a catalytic subunit and a regulatory
CC       subunit by caspase-3 during apoptosis which results in kinase
CC       activation. {ECO:0000269|PubMed:12855683}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18330; AAA41871.1; -; mRNA.
DR   EMBL; AJ230617; CAB75578.1; -; Genomic_DNA.
DR   EMBL; AJ230618; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230619; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230620; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230621; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230622; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230623; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230624; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230625; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230626; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230627; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230628; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230629; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230630; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230631; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230632; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AJ230633; CAB75578.1; JOINED; Genomic_DNA.
DR   EMBL; AF219629; AAF32345.1; -; mRNA.
DR   EMBL; BC076505; AAH76505.1; -; mRNA.
DR   PIR; A28163; KIRTCD.
DR   RefSeq; NP_579841.1; NM_133307.1.
DR   PDB; 1BDY; X-ray; 2.20 A; A/B=1-123.
DR   PDB; 7KND; X-ray; 1.39 A; A=229-281.
DR   PDB; 7KNJ; X-ray; 1.57 A; A=229-281.
DR   PDB; 7KO6; X-ray; 1.80 A; A=229-281.
DR   PDB; 7L92; X-ray; 1.75 A; A/D/G/J/M/P/S/V=229-281.
DR   PDB; 7LCB; X-ray; 1.70 A; A=229-281.
DR   PDB; 7LEO; X-ray; 1.65 A; A/D=229-281.
DR   PDB; 7LF3; X-ray; 1.13 A; A=229-281.
DR   PDBsum; 1BDY; -.
DR   PDBsum; 7KND; -.
DR   PDBsum; 7KNJ; -.
DR   PDBsum; 7KO6; -.
DR   PDBsum; 7L92; -.
DR   PDBsum; 7LCB; -.
DR   PDBsum; 7LEO; -.
DR   PDBsum; 7LF3; -.
DR   AlphaFoldDB; P09215; -.
DR   SMR; P09215; -.
DR   BioGRID; 250924; 10.
DR   IntAct; P09215; 6.
DR   STRING; 10116.ENSRNOP00000025858; -.
DR   BindingDB; P09215; -.
DR   ChEMBL; CHEMBL3633; -.
DR   DrugCentral; P09215; -.
DR   GlyGen; P09215; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; P09215; -.
DR   PhosphoSitePlus; P09215; -.
DR   jPOST; P09215; -.
DR   PaxDb; 10116-ENSRNOP00000025858; -.
DR   GeneID; 170538; -.
DR   KEGG; rno:170538; -.
DR   UCSC; RGD:67383; rat. [P09215-1]
DR   AGR; RGD:67383; -.
DR   CTD; 5580; -.
DR   RGD; 67383; Prkcd.
DR   eggNOG; KOG0694; Eukaryota.
DR   InParanoid; P09215; -.
DR   OrthoDB; 841660at2759; -.
DR   PhylomeDB; P09215; -.
DR   BRENDA; 2.7.11.13; 5301.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-111933; Calmodulin induced events.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-RNO-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-RNO-1489509; DAG and IP3 signaling.
DR   Reactome; R-RNO-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-RNO-450520; HuR (ELAVL1) binds and stabilizes mRNA.
DR   Reactome; R-RNO-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-RNO-5668599; RHO GTPases Activate NADPH Oxidases.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   EvolutionaryTrace; P09215; -.
DR   PRO; PR:P09215; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0036019; C:endolysosome; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016363; C:nuclear matrix; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:diacylglycerol-dependent serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0004699; F:diacylglycerol-dependent, calcium-independent serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0008047; F:enzyme activator activity; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0043560; F:insulin receptor substrate binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0070976; F:TIR domain binding; IPI:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IMP:CACAO.
DR   GO; GO:0042100; P:B cell proliferation; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0071447; P:cellular response to hydroperoxide; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:CACAO.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; ISO:RGD.
DR   GO; GO:0032963; P:collagen metabolic process; IMP:RGD.
DR   GO; GO:0070779; P:D-aspartate import across plasma membrane; IMP:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0051490; P:negative regulation of filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0090331; P:negative regulation of platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0042119; P:neutrophil activation; ISO:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:2000304; P:positive regulation of ceramide biosynthetic process; ISO:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:RGD.
DR   GO; GO:2000753; P:positive regulation of glucosylceramide catabolic process; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:RGD.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; ISO:RGD.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; ISO:RGD.
DR   GO; GO:2000755; P:positive regulation of sphingomyelin catabolic process; ISO:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; ISS:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; ISO:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:2000303; P:regulation of ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0042325; P:regulation of phosphorylation; IDA:CACAO.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0023021; P:termination of signal transduction; ISO:RGD.
DR   CDD; cd20834; C1_nPKC_theta-like_rpt1; 1.
DR   CDD; cd20837; C1_nPKC_theta-like_rpt2; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027436; PKC_delta.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050236; Ser_Thr_kinase_AGC.
DR   PANTHER; PTHR24356:SF427; PROTEIN KINASE C DELTA TYPE; 1.
DR   PANTHER; PTHR24356; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF21494; PKC_C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501104; Protein_kin_C_delta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding; Cell cycle;
KW   Cell membrane; Cytoplasm; Direct protein sequencing; Kinase; Membrane;
KW   Metal-binding; Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Tumor suppressor; Zinc; Zinc-finger.
FT   CHAIN           1..673
FT                   /note="Protein kinase C delta type"
FT                   /id="PRO_0000055696"
FT   CHAIN           1..327
FT                   /note="Protein kinase C delta type regulatory subunit"
FT                   /id="PRO_0000421671"
FT   CHAIN           328..673
FT                   /note="Protein kinase C delta type catalytic subunit"
FT                   /id="PRO_0000421672"
FT   DOMAIN          1..106
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          347..601
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          602..673
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         158..208
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         230..280
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ACT_SITE        471
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         353..361
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         376
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            48
FT                   /note="Interaction with phosphotyrosine-containing peptide"
FT                   /evidence="ECO:0000250"
FT   SITE            62
FT                   /note="Interaction with phosphotyrosine-containing peptide"
FT                   /evidence="ECO:0000250"
FT   SITE            67
FT                   /note="Interaction with phosphotyrosine-containing peptide"
FT                   /evidence="ECO:0000250"
FT   SITE            123
FT                   /note="Interaction with phosphotyrosine-containing peptide"
FT                   /evidence="ECO:0000250"
FT   SITE            327..328
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         43
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P28867"
FT   MOD_RES         50
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         64
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:17562707"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         141
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         155
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:17562707"
FT   MOD_RES         218
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         299
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         311
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:18550549,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         332
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:18550549"
FT   MOD_RES         372
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         449
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         504
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         505
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:17569658,
FT                   ECO:0000269|PubMed:18550549, ECO:0000269|PubMed:9677322"
FT   MOD_RES         565
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05655"
FT   MOD_RES         662
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16396499,
FT                   ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         327..673
FT                   /note="DNNGTYGKIWEGSNRCRLENFTFQKVLGKGSFGKVLLAELKGKERYFAIKYL
FT                   KKDVVLIDDDVECTMVEKRVLALAWENPFLTHLICTFQTKDHLFFVMEFLNGGDLMFHI
FT                   QDKGRFELYRATFYAAEIICGLQFLHGKGIIYRDLKLDNVMLDKDGHIKIADFGMCKEN
FT                   IFGENRASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF
FT                   ESIRVDTPHYPRWITKESKDIMEKLFERDPAKRLGVTGNIRLHPFFKTINWNLLEKRKV
FT                   EPPFKPKVKSPSDYSNFDPEFLNEKPQLSFSDKNLIDSMDQTAFKGFSFVNPKYEQFLE
FT                   -> GESGSHIPLKLPFPDRAREKNSSETWDKTTTGPMARSGRGATGAALRTSPSRKYLA
FT                   KAALARYCLQN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10708593"
FT                   /id="VSP_004742"
FT   MUTAGEN         505
FT                   /note="T->A: Decrease in the phosphorylation level."
FT                   /evidence="ECO:0000269|PubMed:9677322"
FT   CONFLICT        147
FT                   /note="A -> S (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="T -> S (in Ref. 2; CAB75578 and 4; AAH76505)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..13
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          27..35
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          58..62
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          68..76
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          79..87
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   HELIX           88..96
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   TURN            97..100
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          101..107
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          113..122
FT                   /evidence="ECO:0007829|PDB:1BDY"
FT   STRAND          233..236
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   TURN            245..247
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   TURN            262..264
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:7LF3"
FT   HELIX           273..275
FT                   /evidence="ECO:0007829|PDB:7LF3"
SQ   SEQUENCE   673 AA;  77520 MW;  D2C767E55863A23C CRC64;
     MAPFLRISFN SYELGSLQAE DDASQPFCAV KMKEALTTDR GKTLVQKKPT MYPEWKSTFD
     AHIYEGRVIQ IVLMRAAEDP MSEVTVGVSV LAERCKKNNG KAEFWLDLQP QAKVLMCVQY
     FLEDGDCKQS MRSEEEAMFP TMNRRGAIKQ AKIHYIKNHE FIATFFGQPT FCSVCKEFVW
     GLNKQGYKCR QCNAAIHKKC IDKIIGRCTG TATNSRDTIF QKERFNIDMP HRFKVYNYMS
     PTFCDHCGTL LWGLVKQGLK CEDCGMNVHH KCREKVANLC GINQKLLAEA LNQVTQKASR
     KPETPETVGI YQGFEKKTAV SGNDIPDNNG TYGKIWEGSN RCRLENFTFQ KVLGKGSFGK
     VLLAELKGKE RYFAIKYLKK DVVLIDDDVE CTMVEKRVLA LAWENPFLTH LICTFQTKDH
     LFFVMEFLNG GDLMFHIQDK GRFELYRATF YAAEIICGLQ FLHGKGIIYR DLKLDNVMLD
     KDGHIKIADF GMCKENIFGE NRASTFCGTP DYIAPEILQG LKYSFSVDWW SFGVLLYEML
     IGQSPFHGDD EDELFESIRV DTPHYPRWIT KESKDIMEKL FERDPAKRLG VTGNIRLHPF
     FKTINWNLLE KRKVEPPFKP KVKSPSDYSN FDPEFLNEKP QLSFSDKNLI DSMDQTAFKG
     FSFVNPKYEQ FLE
//
